Australian-made coronavirus vaccine COVAX-19 shows promise in clinical trials

Vaxine’s COVID-19 vaccine technology has progressed to the final stages of a human clinical trial, after strong preliminary results demonstrating its ability to prevent coronavirus infections in animal models. This highly effective protein-based vaccine can be manufactured on a large scale and remain stable in normal refrigerated conditions. Read this full article here:Australian-made coronavirus vaccine […]

Can India prevent COVID-19 third wave? Global vaccine expert Professor Nikolai Petrovsky answers

TV9 News spoke to Prof Nikolai Petrovsky, PhD, senior researcher, an expert on vaccine development and director of endocrinology at Flinders medical centre, Flinders University, Australia, to understand the importance of stringent lockdown measures and what can India learn from Australia’s handling of the COVID-19 pandemic. Here is the link to the full article: https://tv9news.com/india/can-india-prevent-covid-19-third-wave-global-vaccine-expert-answers-42504.html […]

Australian government funds $1M for development of Vaxine’s Covax-19® vaccine

The pioneering team at Vaxine who developed the world’s first swine flu vaccine in 2009, has been awarded funding of $1 million dollars from the Biomedical Translation Bridge (BTB) program, an initiative of the Medical Research Future Fund operated by MTPConnect, to help advance Vaxine’s state-of-the-art COVID-19 vaccine candidate called Covax-19®. Sharen Pringle, Vaxine’s Business […]